key: cord-0946663-zfgw8xmy
authors: Ben-Shabat, Shimon; Yarmolinsky, Ludmila; Porat, Daniel; Dahan, Arik
title: Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies
date: 2019-12-01
journal: Drug Deliv Transl Res
DOI: 10.1007/s13346-019-00691-6
sha: 407bf97338d28fafe0ffff4c1997a1942ed881d9
doc_id: 946663
cord_uid: zfgw8xmy

Viral infections affect three to five million patients annually. While commonly used antivirals often show limited efficacy and serious adverse effects, herbal extracts have been in use for medicinal purposes since ancient times and are known for their antiviral properties and more tolerable side effects. Thus, naturally based pharmacotherapy may be a proper alternative for treating viral diseases. With that in mind, various pharmaceutical formulations and delivery systems including micelles, nanoparticles, nanosuspensions, solid dispersions, microspheres and crystals, self-nanoemulsifying and self-microemulsifying drug delivery systems (SNEDDS and SMEDDS) have been developed and used for antiviral delivery of natural products. These diverse technologies offer effective and reliable delivery of medicinal phytochemicals. Given the challenges and possibilities of antiviral treatment, this review provides the verified data on the medicinal plants and related herbal substances with antiviral activity, as well as applied strategies for the delivery of these plant extracts and biologically active phytochemicals. [Figure: see text]

Viral infections remain a major worldwide cause of morbidity and mortality. Among the most aggressive viral infections are Ebola, AIDS (acquired immunodeficiency syndrome), influenza, and SARS (severe acute respiratory syndrome). For instance, influenza is responsible for over 3 million new cases of severe disease, and between 300,000-500,000 deaths yearly [1, 2] . Alarmingly, the number of patients diagnosed with viral infections is increasing every year with more blood transfusions, organ transplantations, and the use of hypodermic syringes.

Classic antiviral drugs such as interferon and ribavirin are effective in vitro against most viruses, but often are ineffective in patients. Ninety different antiviral agents available today [3, 4] only treat a selection of viruses; these viruses include HIV (human immunodeficiency virus), herpes viruses, including HSV (herpes simplex virus), hCMV (human cytomegalovirus), VZV (varicella zoster virus), influenza viruses, and the hepatitis viruses ( Fig. 1) . Currently, there is no approved remedy for many types or viruses, and vaccination is limited to hepatitis A virus, mumps, and varicella [2] . In addition, these agents are often costly and ineffective due to viral resistance and cause side effects. With that in mind, naturally based pharmacotherapy may be a proper alternative for treating viral diseases. Thus, it is necessary to further examine the topic of antiviral phytochemicals, highlighting drug delivery applications in overcoming the multiple biological barriers existing for antiviral agents to successfully reach their intended site(s) of action. The present review focuses on the antiviral properties of herb extracts and bioactive constituent isolates from medicinal plants, and the efforts to obtain their efficient delivery.

Various plants have been used in medicine since ancient times and are known for their strong therapeutic effect. In traditional medicine, diseases of possible viral origin have been treated by many of these plants. The main findings related to antiviral plant extracts are collected in Table 1 . Included extracts were tested in cell culture, and some extracts were also studied in vivo [11, 23, 31, 39] .

Various phytochemicals were isolated, purified, and identified from the crude extracts of alkaloids, terpenes, flavonoids, various glycosides, and proteins (Table 1) . Compounds with antiviral activity are present in many plants, e.g., rutin, a flavonoid glycoside common in different plants, is effective against avian influenza virus [48] , HSV-1, HSV-2 [18] , and parainfluenza-3 virus [49] .

Quercetin, an aglycone of rutin, is a phytochemical abundant in plants and may diminish the replication of many viruses: highly pathogenic influenza virus [50] , rhinovirus [51] , dengue virus type-2 [52] , HSV-1 [53] , poliovirus [54] , adenovirus [53] , Epstein-Barr virus [55] , Mayaro virus [56] , Japanese encephalitis virus [57] , respiratory syncytial virus [58] , and HCV [59, 60] . Its antiviral activity mode was studies in a few cases. Its ability to inhibit HCV by limiting the activity of some heat shock proteins (HSPs) produced by cells in response to exposure to stress which were involved in NS5A (nonstructural protein 5A)-mediated viral IRES (internal ribosome entry site) translation [60] is one well-known mechanism. Another mechanism involved the inhibition of HCV NS3 protease and HCV replication in a subgenomic HCV RNA replicon cell system [59] . Quercetin also inhibits various steps of the rhinoviruses pathogenesis, i.e., endocytosis, viral genome transcription, and protein synthesis [51] . In another case, quercetin was shown to have a more specific mode of action, reducing the replication of dengue virus type-2, but not the processes of viral attachment and entry [52] .

In addition, quercetin and three other flavonoids: 3,3′,4′,5,5′,7-hexahydroxyflavone (myricetin), 3,3′,4′,5,6,7hexahydroxyflavone (quercetagetin), and 5,6,7trihydroxyflavone (baicalein), all effectively inhibited reverse transcriptases from Rauscher murine leukemia virus (RLV) and HIV; quercetin, myricetin, and quercetagetin were also shown to inhibit different DNA polymerase enzymes [61] . The abovementioned flavonoid, myricetin, is abundant in wild plants, nuts, fruits, berries, and vegetables. Ellagic acid and myricetin (from the aronia fruit) were active in cell cultures against different subtypes of influenza viruses including an oseltamivir-resistant strain, and also effective in vivo [62] .

Apigenin (4′,5,7-trihydroxyflavone), an aglycone of the flavone class, is found in many plants and has broad antiviral activities against enterovirus-71 [63] , foot and mouth disease virus [64] , HCV [65] , African swine fever virus (ASFV) [66] , and influenza A virus [67] . Of note, many flavonoids of plant origin have known antiviral properties. For example, out of 22 different flavonoids, six phytochemicals (apigenin, baicalein, biochanin A, kaempferol, luteolin, naringenin) were active against the avian influenza H5N1 virus in human lung epithelial (A549) cells through inhibiting nucleoprotein production [67] . Baicalin (the glucuronide of baicalein) was also active against a wide range of viruses, including enterovirus [68] , dengue virus [69] , respiratory syncytial virus [70] , Newcastle disease virus [71] , human immunodeficiency virus [72] , and hepatitis B virus [73] , and different mechanisms were suggested for its antiviral actions. For example, baicalin inhibits the production of HBV, the templates for viral proteins and HBV-DNA synthesis [73] , and decreases IL-6 and IL-8 production without affecting IP-10 levels, as shown in a study on avian influenza H5N1 virus [67] .

The triterpenoids oleanolic acid and ursolic acid are abundant in the plant kingdom, may be effective against HCV by reducing HCV NS5B RdRp virulence [74] , and can also inhibit enterovirus 71 replication [75] . Lastly, Sambucus nigra L. is an active ingredient in a standardized elderberry extract, effectively used in the treatment of fever, colds, and influenza A and B [76] [77] [78] .

Introducing pharmaceutical nanotechnology into the field of natural medicine is useful and promising. New strategies for the delivery of poorly soluble phytochemicals and plant extracts allow improved pharmacokinetic and clinical outcomes. Commonly used approached such as phytosomes, nanoparticles, hydrogels, microspheres, transferosomes and ethosomes, self-microemulsifying drug delivery systems (SMEDDS), and self-nanoemulsifying drug delivery systems (SNEDDS) have been applied for the delivery of antiviral plant agents (Table 2 ). These antiviral technologies may be preferred over older phytochemical drug formulations due to enhanced solubility and oral absorption, systemic bioavailability, safety, delayed metabolism, and better overall antiviral activity. Yet, very few papers have been published on the topic of antiviral herbal drug delivery, so we wish to display several successful attempts of improving the delivery of phytodrugs with known antiviral activity. Qian et al. [79] attempted to design a selfnanoemulsifying drug delivery system (SNEDDS) to allow greater apparent solubility and oral bioavailability (< 10%) of myricetin. Overall, four formulations were pre- (Fig. 2) . In animal models, the myricetin-loaded SNEDDS formulations exhibited higher plasma myricetin concentrations in all time points compared to the free myricetin. Formulation No. 13 in Fig. 2 had higher intestinal permeability, but showed lower bioavailability attributed to poor lymphatic transport-a main absorption mechanism of myricetin.

Formulation No. 4 and 8, on the other hand, achieved small particle size, required for lymphatic transport (Fig. 2) . Kim et al. [85] tried to increase the oral bioavailability of the low solubility flavonoid apigenin. Different water-in-oilin-water emulsions of apigenin were studied for their physical characteristics, as well as digestibility using in vitro digestion model and in vivo pharmacokinetics in rats. An emulsion of soybean oil-Tween 80 was chosen for pharmacokinetic tests in animal model after proving better stability in terms of particle size and zeta potential. Plasma concentrations of apigenin in the water-in-oil emulsion were markedly higher at different time points and maximal concentration was 9-fold higher compared to apigenin suspension [85] .

Zhang et al. [94] aimed to improve the oral absorption of baicalin, which has low solubility and poor permeability, by using a micellar formulation comprised of the carriers Pluronic P123 copolymer and sodium taurocholate. Sustained release profile of baicalin-loaded mixed micelles, in in vitro drug release experiment, held in several pH conditions, showed 14% drug released after 2 h in gastric conditions and 54% release within 48 h in intestinal conditions, compared to 34% and 79% release [106] [107] [108] [109] [110] , phytosome [111] , nanoliposome [112] , mixed micelles [113, 114] , SNEDDS [115, 116] , nanocarrier [117, 118] Mixed micelles [129, 130] , nanoparticles [131, 132] , solid dispersion [133, 134] , SNEDDS [135] , SMEDDS [136] , lipid carrier [137] , copolymeric micelles [138] , exosomes [139] Naringenin DENV, HCV SNEDDS [140] , solid dispersion [141] , nanoparticles [142, 143] , liposome [144] , nanosuspension [145, 146] In vitro uptake studies, carried out with a caco-2 cell line, determined the absorption of baicalin within the mixed micelles and verified their internalization ability. Baicalin-loaded ST-P123-MMs formulation achieved high oral bioavailability (Fig. 3) . These results are believed to derive from the micellar small size and to Pluronic component, which is a P-glycoprotein inhibitor.

In addition, the mixed micelle formulation showed a bimodal presentation, presumably attributed to enterohepatic recirculation, further enhancing the drug's oral bioavailability [94] . Oleanolic acid has low aqueous solubility and systemic bioavailability (0.7% in rats). SMEDDS was developed in an attempt to overcome these limitations. This delivery system consisted of 50% ethyl oleate (oil), 35% Cremophor EL (surfactant), and 15% alcohol (co-surfactant), allowing a great increase in oleanolic acid solubility [151] . In vitro studies showed a sustained release behavior from SMEDDS. Systemic rat bioavailability was significantly higher in SMEDDS than in the marketed tablets of oleanolic acid (Fig. 4) . The improved drug's oral bioavailability was explained by enhanced solubility and permeability through emulsification and small particle sizes, respectively.

Flos Lonicerae Japonicae and Fructus forsythia are used together in Chinese herbal remedies, and both have antiviral, antibacterial, and antiinflammatory properties. An attempt was made to enhance the bioavailability and antiinfluenza properties of the herb combination by chito-oligosaccharide, a chitosan derivative [122] . In a cell culture antiinfluenza assay, chito-oligosaccharide improved the activity of extracts containing Flos Lonicerae Japonicae and Fructus forsythia, compared to extracts that do not contain the chito-oligosaccharide. The absorption was studied in vitro using Caco-2 model, and higher experimentally derived apparent permeability values were obtained with increasing concentrations [94] with permission of chito-oligosaccharide. In vivo pharmacokinetics showed a significant increase in Flos Lonicerae Japonicae and Fructus forsythia concentrations when co-delivered with chito-oligosaccharide, relative to herb administration alone (Fig. 5a ). In addition, enhanced antiviral effect was achieved in four preparations containing chito-oligosaccharide, which was explained by the higher absorption of caffeic acid derivatives (Fig. 5b) . This work was unique because it studied the effects of the delivery system on both the pharmacokinetic properties and the antiviral activity of the herbal drug, directly.

An inclusion complex of honokiol and sulfobutyl ether-βcyclodextrin was made to enhance the solubility and bioavailability of the herbal drug [148] . In a phase solubility experiment, honokiol solubility linearly increased with growing levels of the cyclodextrin. The in vitro release study showed that the honokiol/cyclodextrin complex allowed enhanced release rate than either honokiol/cyclodextrin physical mixture or honokiol alone. In rat oral pharmacokinetics, AUC and C max values of the inclusion complex were 1.58 and 1.23 times higher relative to honokiol suspension, respectively. Also, honokiol in suspension had 3 times higher body clearance than complexed honokiol.

Andrographolide is sparingly soluble in water, unstable in very acidic and basic conditions, poorly absorbed, and has low oral bioavailability. PLGA (poly(lactic-co-glycolic acid)) was used to form andrographolide loaded microspheres to overcome these limitations [124] . In vitro andrographolidemicrosphere formulation exhibited sustained release profile over 9 days, with just 14% andrographolide release over the first 8 h, because of low drug density at the surface of the delivery system, which also allowed a relatively high oral bioavailability of 67.5%. Lastly, fine correlation was obtained between in vitro drug release and in vivo absorption, indicating that the in vitro assay may be a good predictor of drug absorption in vivo.

Curcumin, a polyphenolic compound with various medical applications including known antivirus activity, is poorly watersoluble and has low oral bioavailability. With N-acetyl L-cysteine and different levels (20, 50, and 100 mg) of polyethylene glycol (PEG), nanostructured solid lipid carriers were synthesized to obtain curcumin mucoadhesion and mucus penetration Fig. 4 Oleanolic acid rat blood levels after oral administration of oleanolic acid-loaded SMEDDS (filled diamonds) and marketed drug product (tablet) (filled squares); upper right: accumulative release of oleanolic acid. Reproduced from [151] with permission Reproduced from [122] with permission [156] . Drug release was characterized in vitro for curcumin solution, curcumin-loaded nanolipid carrier, and curcumin-loaded nanolipid carrier with N-acetyl L-cysteine PEG. From the curcumin solution, 80% of drug was released after 4 h, whereas all the nanolipid formulations allowed sustained curcumin release; the sustained release effect from the modified nanolipid carriers was more pronounced than that of unmodified nanolipids. An SPIP study in rats was then conducted, and results were similar for all three parts of the small intestine: nanolipids allowed enhanced curcumin permeation relative to solution, and so did higher N-acetyl L-cysteine content. Pharmacokinetic study of curcumin solutions (P.O and I.V) and curcumin nanolipid carriers (with N-acetyl L-cysteine PEG content of 0, 20, 50, and 100 mg) was conducted. Similar to the results of the permeability experiment, plasma curcumin concentrations were higher with nanolipid carriers relative to solution (either P.O or I.V) and increased further with higher N-acetyl Lcysteine PEG levels. The area under the curve was substantially larger with the modified nanolipid carriers compared to either curcumin solution or to the unmodified delivery system.

Indeed, modern drug delivery technologies are numerous, and tailoring the most appropriate formulation to the medicinal phytochemical in question is not just a matter of trial and error; rather, the physicochemical properties of the specific natural drug substance determine the delivery issues that the formulator may face, and the excipients that can be used to overcome these challenges [157, 158] . Among the physicochemical properties of importance are log P (a measure of the drug's lipophilicity) and melting point. These parameters will determine the likelihood of the active substance to precipitate in the gastrointestinal lumen, in which case the use of amorphous formulations may be preferred over other oral carriers. Additional important physicochemical properties include the drug's chemical structure and molecular weight; using previously successful formulations to deliver drugs with similar chemical structure may be a wise approach. Also, generally speaking, higher molecular weight substances may be better incorporated into lipid-based drug delivery systems [159] [160] [161] . It should be noted that some solubility-enabling formulations may simultaneously decrease the drug's permeability, and overall absorption may be unimproved. This solubilitypermeability interplay was shown for formulations based on cyclodextrins [162] [163] [164] , surfactants [165] , cosolvents [166] , and hydrotropes [167, 168] . In amorphous solid dispersions (ASD), on the other hand, the solubility increases (via supersaturation) with unchanged permeability, and thus, ASD may be preferred over other carrier systems, given supersaturation can be achieved and maintained for sufficient time [169] .

Altogether, the evidence presented in this work supports the notion that medicinal plants have promising therapeutic potential, especially in the case of herb products against viral infections. Further research on the mechanisms by which phytochemicals exhibit their antiviral effect will allow the developing of successful target-specific drug delivery systems. At the moment, we cannot ensure the plant phytochemicals directly reach viruses or the correct structures inside cells. Ideally, we would have smart pharmaceutical nanotechnologies and targeting strategies that can avoid cellular defenses, transport drugs to targeted intracellular sites, and release the drugs in response to specific molecular signals. Literature also lacks randomized clinical trials to discern the strength of new herbal antiviral drug delivery systems. It is our hope that in the future more high quality clinically relevant studies will accumulate in the literature, which will shed light on the full potential of phytochemicals as novel antiviral agents in adequate delivery systems.

Conflict of interest The authors declare that they have no conflict of interest. 

Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly

Current antiviral drugs and their analysis in biological materials -part II: antivirals against hepatitis and HIV viruses

Antiviral screening of forty-two Egyptian medicinal plants

Studies on the antidiarrhoeal activity of Aegle marmelos unripe fruit: validating its traditional usage

A review study on the effect of Iranian herbal medicines against in vitro replication of herpes simplex virus

In vitro anti-rotavirus activity of some medicinal plants used in Brazil against diarrhea

Screening of some Tanzanian medicinal plants from Bunda district for antibacterial, antifungal and antiviral activities

Preventive effects of a major component of green tea, epigallocathechin-3-gallate, on hepatitis-B virus DNA replication

A protein with antiproliferative, antifungal and HIV-1 reverse transcriptase inhibitory activities from caper H1N1 influenza clinical symptoms in murine lung tissues putatively due to enhanced natural killer cell activity

Anti-HIV activity of medicinal plant extracts

In-vitro antiviral activity of Solanum nigrum against hepatitis C virus

Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: in-vitro and In silico study

Anti-influenza virus effect of aqueous extracts from dandelion

The effect of root, shoot and seed extracts of the Iranian Thymus L. (Family: Lamiaceae) species on HIV-1 replication and CD4 expression

Ellagitannins from Tuberaria lignosa as entry inhibitors of HIV

Anti-hepatitis B virus activities of friedelolactones from Viola diffusa Ging

Anti herpes simplex-1 activity of a standard extract of Zataria multiflora Boiss

Anti-H5N1 virus flavonoids from Capparis sinaica Veill

Antibacterial, antifungal, and antiviral activities of some flavonoids

Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry

Quercetin inhibits rhinovirus replication in vitro and in vivo

Antiviral activity of four types of bioflavonoid against dengue virus type-2

In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids

Quercetinase pirin makes poliovirus replication resistant to flavonoid quercetin

Quercetin-induced apoptosis prevents EBV infection

Quercetin and quercetin 3-O-glycosides from Bauhinia longifolia (Bong.) Steud. show anti-Mayaro virus activity

Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus

Studies on antiviral constituents in stems and leaves of Pithecellibium clypearia

Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity

The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production

Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases

Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses

Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors

Apigenin restricts FMDV infection and inhibits viral IRES driven translational activity

The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels

Apigenin inhibits African swine fever virus infection in vitro

Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells

The antiviral effect of baicalin on enterovirus 71 in vitro

Baicalin, a metabolite of baicalein with antiviral activity against dengue virus

Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice

Anti-NDVactivity of baicalin from a traditional Chinese medicine in vitro

Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry

Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs

Oleanolic acid and ursolic acid: novel hepatitis C virus antivirals that inhibit NS5B activity

Inhibition of human enterovirus 71 replication by pentacyclic triterpenes and their novel synthetic derivatives

Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama

Inhibitory activity of a standardized elderberry liquid extract against clinically relevant human respiratory bacterial pathogens and influenza A and B viruses

Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections

Selfnanoemulsifying drug delivery systems of myricetin: formulation development, characterization, and in vitro and in vivo evaluation

Preparation and evaluation of chitosan-based nanogels/gels for oral delivery of myricetin

Pluronic-based micelle encapsulation potentiates myricetininduced cytotoxicity in human glioblastoma cells

Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation

A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram

Effect of beta-cyclodextrin on the molecular properties of myricetin upon nano-encapsulation: insight from optical spectroscopy and quantum chemical studies

Enhancing oral bioavailability using preparations of apigenin-loaded W/O/W emulsions: in vitro and in vivo evaluations

A pH-sensitive microemulsion-filled gellan gum hydrogel encapsulated apigenin: Characterization and in vitro release kinetics

Dissolution and bioavailability improvement of bioactive apigenin using solid dispersions prepared by different techniques

Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersion

Improved solubility and oral bioavailability of apigenin via Soluplus/Pluronic F127 binary mixed micelles system

Formulation and characterization of an apigenin-phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential

Controlled release oral delivery of apigenin containing pellets with antioxidant activity

Design and evaluation of a self-microemulsifying drug delivery system for apigenin

Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes

In vitro and in vivo study of Baicalin-loaded mixed micelles for oral delivery

Preparation, optimization, characterization and cytotoxicity in vitro of baicalin-loaded mixed micelles

Enhanced efficacy of baicalin-loaded TPGS polymeric micelles against periodontitis

Optimization of quality attributes and atomic force microscopy imaging of reconstituted nanodroplets in baicalin loaded selfnanoemulsifying formulations

Formulation optimization and the absorption mechanisms of nanoemulsion in improving baicalin oral exposure

The formation of a host-guest inclusion complex system between betacyclodextrin and baicalin and its dissolution characteristics

Characterization and bioavailability study of baicalinmesoporous carbon nanopowder solid dispersion

Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB

Characterization and evaluation in vivo of baicalinnanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method

Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal

Preparation and evaluation of self-microemulsifying drug delivery system of baicalein

Maltodextrin fast dissolving films for quercetin nanocrystal delivery. A feasibility study

Capital IE, Cyrillic valuation of biocompatibility and antioxidant efficiency of chitosan-alginate nanoparticles loaded with quercetin

Development and evaluation of PLGA polymer based nanoparticles of quercetin

Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats

Application of pH-responsive fucoidan/chitosan nanoparticles to improve oral quercetin delivery

Self-assembly, functionality, and in-vitro properties of quercetin loaded nanoparticles based on shellacalmond gum biological macromolecules

Improved oral absorption of quercetin from quercetin phytosome(R), a new delivery system based on food grade lecithin

Enhanced bioactivity and efficient delivery of quercetin through nanoliposomal encapsulation using rice bran phospholipids

Preparation and in vitro and in vivo evaluation of quercetin-loaded mixed micelles for oral delivery

Pharmacokinetics of quercetin-loaded methoxy poly(ethylene glycol)-b-poly(L-lactic acid) micelle after oral administration in rats

Enhancement of quercetin oral bioavailability by self-nanoemulsifying drug delivery system and their quantification through ultra high performance liquid chromatography and mass spectrometry in cerebral ischemia

Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability

Lipid-based nanocarrier for quercetin delivery: system characterization and molecular interactions studies

Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: biochemical, pharmacokinetic and biodistribution evidences

Anti-inflammatory effect and toxicology analysis of oral delivery quercetin nanosized emulsion in rats

Development of nanosuspension formulation for oral delivery of quercetin

Effect of chitooligosaccharide on the intestinal absorptions of phenylethanoid glycosides in Fructus Forsythiae extract

Study on the rationality for antiviral activity of Flos Lonicerae japonicaefructus Forsythiae herb chito-oligosaccharide via Integral Pharmacokinetics

Liquid and solid self-microemulsifying drug delivery systems for improving the oral bioavailability of andrographolide from a crude extract of Andrographis paniculata

Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation

Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-alpha-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate

Design and evaluation of novel solid self-nanodispersion delivery system for andrographolide

Preparation of andrographolide-loaded solid lipid nanoparticles and their in vitro and in vivo evaluations: characteristics, release, absorption, transports, pharmacokinetics, and antihyperlipidemic activity

Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin

Pluronic-based mixed polymeric micelles enhance the therapeutic potential of curcumin

Evaluation in vitro and in vivo of curcumin-loaded mPEG-PLA/TPGS mixed micelles for oral administration

Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations

Chitosan/alginate nanoparticles as a promising carrier of novel curcumin diethyl diglutarate

Novel selfnanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatform for oral delivery of curcumin

Involvement of metabolism-permeability in enhancing the oral bioavailability of curcumin in excipient-free solid dispersions co-formed with piperine

In vivo evaluation of a selfnanoemulsifying drug delivery system for curcumin

Enhanced oral bioavailability of curcumin using a supersaturatable self-microemulsifying system incorporating a hydrophilic polymer; in vitro and in vivo investigations

Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers

Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles

Exosomes for the enhanced tissue bioavailability and efficacy of curcumin

Selfnanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation

Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier

Potential of cationicpolymeric nanoparticles for oral delivery of naringenin: in vitro and in vivo investigations

Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics

Enhanced solubility and bioavailability of naringenin via liposomal nanoformulation: preparation and in vitro and in vivo evaluations

Formulation and evaluation of naringenin nanosuspensions for bioavailability enhancement

Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability

Enhancement of naringenin bioavailability by complexation with hydroxypropyl-beta-cyclodextrin

Investigation of inclusion complex of honokiol with sulfobutyl ether-beta-cyclodextrin

Synthesis, structural and in vitro studies of well-dispersed monomethoxypoly(ethylene glycol)-honokiol conjugate micelles

Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsiloncaprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro

Self-microemulsifying drug delivery system for improved oral bioavailability of oleanolic acid: design and evaluation

Preparation, characterization, and in vitro/vivo studies of oleanolic acid-loaded lactoferrin nanoparticles

Formulation, biological and pharmacokinetic studies of sucrose ester-stabilized nanosuspensions of oleanolic Acid

Development and evaluation of optimized sucrose ester stabilized oleanolic acid nanosuspensions prepared by wet ball milling with design of experiments

Formulation development and bioavailability evaluation of a selfnanoemulsified drug delivery system of oleanolic acid

N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations

Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies

Advances in nanoparticle and microparticle delivery systems for increasing the dispersibility, stability, and bioactivity of phytochemicals

Lipid-based oral formulation strategies for lipophilic drugs

The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats

Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs

The use of captisol (SBE7-beta-CD) in oral solubility-enabling formulations: comparison to HPbetaCD and the solubility-permeability interplay

The interaction of nifedipine with selected cyclodextrins and the subsequent solubility-permeability trade-off

Predicting the solubility-permeability interplay when using cyclodextrins in solubility-enabling formulations: model validation

Theoretical and experimental studies of transport of micelle-solubilized solutes

Striking the optimal solubility-permeability balance in oral formulation development for lipophilic drugs: maximizing Carbamazepine blood levels

Methacrylate-copolymer Eudragit EPO as a solubility-enabling excipient for anionic drugs: investigation of drug solubility, intestinal permeability, and their interplay

Hydrotropic solubilization of lipophilic drugs for oral delivery: the effects of urea and nicotinamide on carbamazepine solubility-permeability interplay

The solubilitypermeability interplay and oral drug formulation design: two heads are better than one

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations